Evidence map›Paper›PMID 23603911›Full record

ArticleThe Journal of biological chemistry2013

Structural reevaluation of Streptococcus pneumoniae Lipoteichoic acid and new insights into its immunostimulatory potency.

Nicolas Gisch, Thomas Kohler, Artur J Ulmer, Johannes Müthing, Thomas Pribyl, Kathleen Fischer, Buko Lindner, Sven Hammerschmidt, Ulrich Zähringer

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 109 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. d-Alanylation of Lipoteichoic Acids inFrontiers in microbiology · 2022
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Nicolas GischDivision of Immunochemistry, Leibniz-Center for Medicine and Biosciences, Borstel, Germany. ngisch@fz-borstel.de
Thomas Kohler
Artur J Ulmer
Johannes Müthing
Thomas Pribyl
Kathleen Fischer
Buko Lindner
Sven Hammerschmidt
Ulrich Zähringer
ImmunoChemistry Technologies (United States) · USUniversität Greifswald · DEInnate Pharma (France) · FRResearch Center Borstel - Leibniz Lung Center · DEUniversity of Münster · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Streptococcus pneumoniae is a Gram-positive human pathogen with a complex lipoteichoic acid (pnLTA) structure. Because the current structural model for pnLTA shows substantial inconsistencies, we reinvestigated purified and, more importantly, O-deacylated pnLTA, which is most suitable for NMR spectroscopy and electrospray ionization-MS spectrometry. We analyzed pnLTA of nonencapsulated pneumococcal strains D39Δcps and TIGR4Δcps, respectively. The data obtained allowed us to (re)define (i) the position and linkage of the repeating unit, (ii) the putative α-GalpNAc substitution at the ribitiol 5-phosphate (Rib-ol-5-P), and (iii) the length of (i.e. the number of repeating units in) the pnLTA chain. We here also describe for the first time that the terminal sugar residues in the pnLTA (Forssman disaccharide; α-D-GalpNAc-(1→3)-β-D-GalpNAc-(1→)), responsible for the cross-reactivity with anti-Forssman antigen antibodies, can be heterogeneous with respect to its degree of phosphorylcholine substitution in both O-6-positions. To assess the proinflammatory potency of pnLTA, we generated a (lipopeptide-free) Δlgt mutant of strain D39Δcps, isolated its pnLTA, and showed that it is capable of inducing IL-6 release in human mononuclear cells, independent of TLR2 activation. This finding was quite in contrast to LTA of the Staphylococcus aureus SA113Δlgt mutant, which did not activate human mononuclear cells in our experiments. Remarkably, this is also contrary to various other reports showing a proinflammatory potency of S. aureus LTA. Taken together, our study refines the structure of pnLTA and indicates that pneumococcal and S. aureus LTAs differ not only in their structure but also in their bioactivity.

Indexed as

Adjuvants, ImmunologicLipopolysaccharidesModels, MolecularTeichoic AcidsAntibodies, BacterialAntibodies, HeterophileHumansInterleukin-6Leukocytes, MononuclearMaleMutationSpecies SpecificityStaphylococcus aureusStreptococcus pneumoniaeToll-Like Receptor 2Adjuvants, ImmunologicAntibodies, BacterialAntibodies, HeterophileIL6 protein, humanInterleukin-6Lipopolysaccharideslipoteichoic acidTeichoic AcidsTLR2 protein, humanToll-Like Receptor 2Analytical ChemistryForssman AntigenImmunostimulatory PotencyInnate ImmunityLipoteichoic AcidMass Spectrometry (MS)NMRStreptococcus pneumoniaeStructural Biology

Identifiers

PMID23603911
PMCPMC3668725
OpenAlexW2049940196

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.